
AlphaFold3 is out (and closed source 🤯😠)! So … how well does it do on peptide-protein complexes? A continuing thread as we run predictions...

Structural basis of peptide-mediated protein communication and function @HebrewU Member of @RosettaCommons. Tweets by lab members. 🦋 furmanlab.bsky.social 🦋

AlphaFold3 is out (and closed source 🤯😠)! So … how well does it do on peptide-protein complexes? A continuing thread as we run predictions...

🦋 Find us also on bluesky 🦋 furmanlab.bsky.social

Try it and let us know how it goes! @BenLehner @xiaotianliao @sokrypton @amoseslab

If you want to integrate it in your own AF3 installation, check the 3 files which only need a slight modification (model.py, confidences.py and confidence_types.py): github.com/Kuhlman-Lab/alpha…

We used the Kuhlman lab’s version of AF3, as this also makes the mmseqs2 server available for generating MSA (thank you Brian Kuhlman and Henry Dieckhaus): github.com/Kuhlman-Lab/alpha… No flags required, actifptm is part of the json output (also calculated between chains).

🚨 actifpTM is now in AF3 🚨 Since our new metric, actifpTM, was determined to be the best for predicting success in designed proteins refolded by AF2 (biorxiv.org/content/10.1101/… by @TimothyPJenkins), we made it available also in AF3!
Our work on refining AlphaFold2’s ipTM has been accepted for publication in Bioinformatics @OxfordJournals We have been questioning why ipTM worsens when docking peptides with disordered flanking regions, and modified the calculation to remove this effect. Let’s dive in! 👇

🚨The Bits to Binders Competition has concluded!🧬 One year ago we gathered scientists from around the world to design and submit protein binders that cause immune cells to target and eliminate CD20+ tumors Spoiler: They work!

1/13 🧵 Today, Bindcraft was published in @Nature , one of the most famous AIs in biology for designing protein–protein interactions (PPI). In my opinion. Bindcraft represents one of the most important advances in the post–AlphaFold2 era.

I am super excited to announce that I will be starting my lab at the Department of Pharmacology of the University of Zurich in Switzerland next year!

5/ This was an amazing collaboration with the @lab_wiener and @RouvinskiLab - thank you! 🙌 Graphical abstract below ⬇️ #SARSCoV2 #COVID19 #Virology #CellReports #ComplementSystem #Immunology

4/ 💡 Heparin analogs (like Enoxaparin) block NP surface binding, preventing immune complex formation and rescuing cells from complement attack. A possible path to reduce immunopathology.

3/ Complement attack leads to C3b deposition on nearby cells, a potentially pathogenic immune event in COVID-19. 🧠But there’s a therapeutic angle...

2/ NP transfers from infected to neighboring uninfected cells, where it binds heparan sulfate proteoglycans (HSPGs) via its positively charged RNA-binding regions. This creates targets for anti-NP IgGs to trigger complement activation.

1/ 🚨Excited to share our new work in Cell Reports! We reveal how SARS-CoV-2 nucleocapsid protein (NP) directs complement attack on uninfected cells, a surprising immune evasion twist. 🔗 cell.com/cell-reports/fullte…

Our paper is out on biorxiv! Very excited to share our results - we find signal peptides might be structurally important for quite a few protein isoforms. Full thread soon!
Signal peptides as potential structural modulators of human splice isoforms biorxiv.org/content/10.1101/… #biorxiv_bioinfo

If you missed out on Sarel Fleishman's extraordinary talk last night, have no fear - you can check out the recording 👇 youtu.be/2aaWh8yVq8U